Silo Pharma attends IPAC-RS Nasal Innovation Forum, spotlights SPC-15 nose-to-brain PTSD delivery technology
SILO•Silo Pharma to participate in nasal innovation forum
Silo Pharma will participate in the IPAC-RS 2026 Nasal Innovation Forum on Sept. 16-17, 2026, in Jersey City, New Jersey.
The focus will be its patented nose-to-brain delivery program SPC-15 for PTSD, a core asset in its CNS pipeline.
